系统综述:益生菌的使用对炎症性肠病患者有好处吗?

Marselli Taubner Mascarenhas, Sofia Oliveira de Melo, A. Cunha, Ivone Catarina Ferreira
{"title":"系统综述:益生菌的使用对炎症性肠病患者有好处吗?","authors":"Marselli Taubner Mascarenhas, Sofia Oliveira de Melo, A. Cunha, Ivone Catarina Ferreira","doi":"10.11606/issn.1679-9836.v102i3e-201379","DOIUrl":null,"url":null,"abstract":"Objectives: To review the literature that assesses whether the use of probiotics generates benefits for individuals with IBD and to describe the mechanisms of action of probiotics in the pathogenesis of inflammatory bowel disease. Methods: This is a study classified as a systematic review. The selected publications were submitted to the Jadad Scale criteria to assess methodological quality. 15 articles were selected. Results: Of the five clinical trials that used placebo, only 1 did not show benefits from the use of probiotic therapy. The remainder showed a reduction in signs and symptoms and acute phase reagents or induction of remission in the groups treated with probiotics compared to placebo. Conclusion: The present systematic review suggests that the use of probiotics is beneficial in patients with IBD.","PeriodicalId":91041,"journal":{"name":"Revista de medicina","volume":"644 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Revisão sistemática: o uso de probióticos gera benefícios para pacientes em tratamento de doenças inflamatórias intestinais?\",\"authors\":\"Marselli Taubner Mascarenhas, Sofia Oliveira de Melo, A. Cunha, Ivone Catarina Ferreira\",\"doi\":\"10.11606/issn.1679-9836.v102i3e-201379\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: To review the literature that assesses whether the use of probiotics generates benefits for individuals with IBD and to describe the mechanisms of action of probiotics in the pathogenesis of inflammatory bowel disease. Methods: This is a study classified as a systematic review. The selected publications were submitted to the Jadad Scale criteria to assess methodological quality. 15 articles were selected. Results: Of the five clinical trials that used placebo, only 1 did not show benefits from the use of probiotic therapy. The remainder showed a reduction in signs and symptoms and acute phase reagents or induction of remission in the groups treated with probiotics compared to placebo. Conclusion: The present systematic review suggests that the use of probiotics is beneficial in patients with IBD.\",\"PeriodicalId\":91041,\"journal\":{\"name\":\"Revista de medicina\",\"volume\":\"644 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de medicina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11606/issn.1679-9836.v102i3e-201379\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de medicina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11606/issn.1679-9836.v102i3e-201379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:回顾评估使用益生菌是否对IBD患者有益的文献,并描述益生菌在炎症性肠病发病机制中的作用机制。方法:这是一项被归类为系统综述的研究。选定的出版物按照Jadad比额表标准提交,以评估方法质量。15篇文章入选。结果:在使用安慰剂的5项临床试验中,只有1项没有显示使用益生菌治疗的益处。与安慰剂相比,使用益生菌治疗组的其余患者表现出体征和症状的减少,急性期试剂或缓解的诱导。结论:本系统综述提示益生菌对IBD患者有益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Revisão sistemática: o uso de probióticos gera benefícios para pacientes em tratamento de doenças inflamatórias intestinais?
Objectives: To review the literature that assesses whether the use of probiotics generates benefits for individuals with IBD and to describe the mechanisms of action of probiotics in the pathogenesis of inflammatory bowel disease. Methods: This is a study classified as a systematic review. The selected publications were submitted to the Jadad Scale criteria to assess methodological quality. 15 articles were selected. Results: Of the five clinical trials that used placebo, only 1 did not show benefits from the use of probiotic therapy. The remainder showed a reduction in signs and symptoms and acute phase reagents or induction of remission in the groups treated with probiotics compared to placebo. Conclusion: The present systematic review suggests that the use of probiotics is beneficial in patients with IBD.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信